Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.

Abstract

BACKGROUND Up to 20% of patients with ulcerative colitis (UC) become steroid-dependent during their course. Thiopurines are recommended in steroid-dependent UC, but their efficacy is debated. Data exploring the use of infliximab in these patients are scarce. Aims of this study were to evaluate the effectiveness of infliximab in steroid-dependent UC and… (More)
DOI: 10.1097/MIB.0b013e3182802909

Topics

12 Figures and Tables

Cite this paper

@article{Armuzzi2013InfliximabIS, title={Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.}, author={Alessandro Armuzzi and Daniela Pugliese and Silvio Danese and Gianluca Rizzo and Carla Felice and Manuela Marzo and Gialuca Andrisani and Gionata Fiorino and Orsola R Sociale and Alfredo Papa and Italo De Vitis and Gian Lodovico Rapaccini and Luisa Guidi}, journal={Inflammatory bowel diseases}, year={2013}, volume={19 5}, pages={1065-72} }